Altimmune Inc. (NASDAQ:ALT) saw its stock tumble by 37% after releasing topline data from its Phase 2b IMPACT trial ...

Madrigal Pharmaceuticals (NASDAQ:MDGL) and Viking Therapeutics (NASDAQ:VKTX) were among notable gainers on Thursday as ...

Michter’s 2025 Legacy Series features two limited releases: Bomberger’s Declaration Kentucky Straight Bourbon (54% ABV) and ...

From the outset, the cast of the television series MASH was a solid ensemble of performers, led by Alan Alda, who ...

Altimmune, Inc.'s Pemvidutide shows promise in MASH treatment with liver improvements and safety, despite market overreaction. Click for my ALT stock update.

Shares of Altimmune tumbled after the company failed to achieve statistical significance on one of the dual primary endpoints in a recent trial evaluating its drug, pemvidutide, for metabolic ...

First product candidate to demonstrate significant MASH effects and weight loss at 24 weeks Trial met its primary endpoint with statistically significant MASH resolution without worsening of fibrosis ...

Rivus Pharmaceuticals’ fat-busting, muscle-sparing drug candidate reduced liver fat in a phase 2 trial while showcasing the ...

Bathed in golden-hour light, the BeltLine, a pedestrian thoroughfare in Atlanta, had an enchanting atmosphere on the Thursday ...

The clinical-stage biopharmaceutical company reported that the trial met its primary endpoint, with up to 59.1% of participants achieving MASH resolution without worsening of fibrosis in an ...

Miley Cyrus performed a mash-up of "The Climb" and "We Can't Stop" for Spotify Billions Club Live concert in Paris, plus more ...

Alex Garland and Danny Boyle have reunited for a follow-up to their 2002 classic. It has visual flair, terrifying adversaries ...